 Shiv Kumar Agarwal
Concepts (227)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 11 | 2024 | 200 | 5.230 |
Why?
| | Percutaneous Coronary Intervention | 14 | 2022 | 300 | 3.100 |
Why?
| | Fractional Flow Reserve, Myocardial | 9 | 2022 | 126 | 2.380 |
Why?
| | Coronary Artery Disease | 9 | 2022 | 281 | 2.090 |
Why?
| | Coronary Stenosis | 3 | 2021 | 99 | 1.300 |
Why?
| | Hospitalization | 6 | 2024 | 677 | 1.020 |
Why?
| | Coronary Occlusion | 3 | 2021 | 78 | 0.950 |
Why?
| | Coronary Angiography | 11 | 2022 | 360 | 0.950 |
Why?
| | Treatment Outcome | 20 | 2022 | 5265 | 0.820 |
Why?
| | Diabetes Mellitus | 2 | 2023 | 281 | 0.810 |
Why?
| | Technology | 4 | 2022 | 20 | 0.770 |
Why?
| | Humans | 51 | 2024 | 50419 | 0.760 |
Why?
| | Racism | 1 | 2023 | 60 | 0.760 |
Why?
| | Iodide Peroxidase | 1 | 2021 | 5 | 0.760 |
Why?
| | Podocytes | 1 | 2021 | 19 | 0.750 |
Why?
| | Blood Glucose | 5 | 2024 | 447 | 0.730 |
Why?
| | Homeostasis | 1 | 2021 | 203 | 0.680 |
Why?
| | Aneurysm, False | 1 | 2020 | 42 | 0.670 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2024 | 515 | 0.660 |
Why?
| | Blood Glucose Self-Monitoring | 3 | 2024 | 40 | 0.610 |
Why?
| | Hemodynamics | 2 | 2017 | 263 | 0.610 |
Why?
| | Myocardial Ischemia | 2 | 2016 | 112 | 0.580 |
Why?
| | Coronary Vessels | 5 | 2021 | 164 | 0.570 |
Why?
| | Young Adult | 12 | 2024 | 4075 | 0.560 |
Why?
| | Renal Dialysis | 6 | 2018 | 171 | 0.530 |
Why?
| | Cardiac Catheterization | 4 | 2020 | 223 | 0.510 |
Why?
| | Male | 33 | 2024 | 25866 | 0.500 |
Why?
| | Angioplasty, Balloon | 2 | 2019 | 67 | 0.500 |
Why?
| | Acute Kidney Injury | 5 | 2018 | 302 | 0.500 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2015 | 567 | 0.480 |
Why?
| | Postpericardiotomy Syndrome | 1 | 2015 | 4 | 0.480 |
Why?
| | Pericardiectomy | 1 | 2015 | 6 | 0.480 |
Why?
| | Colchicine | 1 | 2015 | 24 | 0.470 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2015 | 30 | 0.470 |
Why?
| | Pericarditis | 1 | 2015 | 21 | 0.470 |
Why?
| | Secondary Prevention | 1 | 2015 | 80 | 0.460 |
Why?
| | Hypertension | 3 | 2020 | 545 | 0.450 |
Why?
| | Awareness | 1 | 2014 | 27 | 0.440 |
Why?
| | Emigrants and Immigrants | 1 | 2014 | 37 | 0.430 |
Why?
| | Middle Aged | 22 | 2024 | 12579 | 0.420 |
Why?
| | Stents | 5 | 2022 | 344 | 0.420 |
Why?
| | Aged | 20 | 2024 | 9738 | 0.380 |
Why?
| | Female | 23 | 2024 | 27053 | 0.360 |
Why?
| | Retrospective Studies | 13 | 2024 | 6274 | 0.340 |
Why?
| | United States | 11 | 2024 | 5005 | 0.330 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 485 | 0.330 |
Why?
| | Adult | 14 | 2024 | 13561 | 0.330 |
Why?
| | Healthcare Disparities | 2 | 2024 | 280 | 0.320 |
Why?
| | Prostatic Neoplasms | 2 | 2023 | 386 | 0.320 |
Why?
| | Time Factors | 8 | 2020 | 2933 | 0.310 |
Why?
| | Predictive Value of Tests | 7 | 2022 | 924 | 0.300 |
Why?
| | Drug-Eluting Stents | 3 | 2018 | 93 | 0.290 |
Why?
| | Risk Factors | 11 | 2022 | 3712 | 0.290 |
Why?
| | Angioplasty, Balloon, Coronary | 2 | 2018 | 137 | 0.260 |
Why?
| | Hospital Mortality | 5 | 2022 | 411 | 0.240 |
Why?
| | Longitudinal Studies | 2 | 2024 | 732 | 0.220 |
Why?
| | Prospective Studies | 4 | 2024 | 2378 | 0.220 |
Why?
| | Receptors, CXCR | 1 | 2023 | 1 | 0.220 |
Why?
| | Kinetochores | 1 | 2023 | 3 | 0.210 |
Why?
| | Receptors, Androgen | 1 | 2023 | 45 | 0.210 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2023 | 36 | 0.210 |
Why?
| | Odds Ratio | 4 | 2017 | 550 | 0.210 |
Why?
| | Microtubule-Associated Proteins | 1 | 2023 | 66 | 0.210 |
Why?
| | Adolescent | 7 | 2024 | 6453 | 0.200 |
Why?
| | Heart Failure | 2 | 2018 | 531 | 0.200 |
Why?
| | Hyperglycemia | 1 | 2022 | 81 | 0.190 |
Why?
| | Cell Cycle Proteins | 1 | 2023 | 163 | 0.190 |
Why?
| | Puromycin Aminonucleoside | 1 | 2021 | 1 | 0.190 |
Why?
| | Integrin alphaVbeta3 | 1 | 2021 | 3 | 0.190 |
Why?
| | Receptors, Thyrotropin | 1 | 2021 | 8 | 0.190 |
Why?
| | Hypotension, Controlled | 1 | 2021 | 3 | 0.190 |
Why?
| | Triiodothyronine | 1 | 2021 | 29 | 0.190 |
Why?
| | Thyroid Hormones | 1 | 2021 | 20 | 0.190 |
Why?
| | Nuclear Proteins | 1 | 2023 | 235 | 0.190 |
Why?
| | Proteinuria | 1 | 2021 | 37 | 0.190 |
Why?
| | Multivariate Analysis | 3 | 2017 | 583 | 0.180 |
Why?
| | Minority Groups | 1 | 2022 | 130 | 0.180 |
Why?
| | Aortic Valve Stenosis | 1 | 2022 | 61 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 3 | 2017 | 462 | 0.180 |
Why?
| | Heart Valve Prosthesis | 1 | 2022 | 79 | 0.180 |
Why?
| | Aorta | 2 | 2019 | 159 | 0.170 |
Why?
| | Quality Improvement | 1 | 2022 | 215 | 0.170 |
Why?
| | Pericardium | 1 | 2020 | 28 | 0.170 |
Why?
| | Reproducibility of Results | 2 | 2021 | 1181 | 0.170 |
Why?
| | Prevalence | 1 | 2023 | 967 | 0.170 |
Why?
| | Diabetes Complications | 1 | 2020 | 116 | 0.170 |
Why?
| | Heart-Assist Devices | 2 | 2018 | 156 | 0.160 |
Why?
| | Area Under Curve | 2 | 2016 | 179 | 0.160 |
Why?
| | Enbucrilate | 1 | 2019 | 7 | 0.160 |
Why?
| | Tissue Adhesives | 1 | 2019 | 13 | 0.160 |
Why?
| | Follow-Up Studies | 4 | 2018 | 2231 | 0.160 |
Why?
| | Heart Injuries | 1 | 2019 | 15 | 0.160 |
Why?
| | Arterial Pressure | 1 | 2019 | 45 | 0.160 |
Why?
| | Prognosis | 4 | 2018 | 1974 | 0.160 |
Why?
| | Brain Ischemia | 2 | 2015 | 163 | 0.160 |
Why?
| | Mice, Knockout | 1 | 2021 | 840 | 0.150 |
Why?
| | Signal Transduction | 2 | 2023 | 1608 | 0.150 |
Why?
| | Exercise Test | 2 | 2016 | 131 | 0.150 |
Why?
| | Cells, Cultured | 1 | 2021 | 1563 | 0.140 |
Why?
| | Atrial Fibrillation | 2 | 2016 | 188 | 0.140 |
Why?
| | Algorithms | 1 | 2021 | 624 | 0.140 |
Why?
| | Population Surveillance | 1 | 2018 | 163 | 0.140 |
Why?
| | Patient Discharge | 2 | 2018 | 318 | 0.130 |
Why?
| | Lower Extremity | 1 | 2017 | 92 | 0.130 |
Why?
| | Hyperemia | 1 | 2016 | 18 | 0.130 |
Why?
| | Transition to Adult Care | 1 | 2016 | 17 | 0.130 |
Why?
| | Recurrence | 2 | 2016 | 657 | 0.130 |
Why?
| | Angina, Stable | 1 | 2016 | 7 | 0.130 |
Why?
| | Angina, Unstable | 1 | 2016 | 22 | 0.130 |
Why?
| | Peripheral Arterial Disease | 1 | 2017 | 69 | 0.130 |
Why?
| | Incidence | 5 | 2018 | 1027 | 0.130 |
Why?
| | Adenosine | 1 | 2016 | 71 | 0.130 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 1796 | 0.130 |
Why?
| | Vasodilator Agents | 1 | 2016 | 96 | 0.130 |
Why?
| | Ventricular Function, Left | 2 | 2018 | 169 | 0.130 |
Why?
| | Patient Readmission | 1 | 2018 | 229 | 0.130 |
Why?
| | Chest Pain | 1 | 2016 | 55 | 0.130 |
Why?
| | Stroke | 2 | 2015 | 495 | 0.120 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 202 | 0.120 |
Why?
| | Vascular Surgical Procedures | 1 | 2017 | 165 | 0.120 |
Why?
| | Acute Coronary Syndrome | 1 | 2016 | 76 | 0.120 |
Why?
| | Constriction, Pathologic | 1 | 2015 | 93 | 0.120 |
Why?
| | Tubulin Modulators | 1 | 2015 | 27 | 0.120 |
Why?
| | Vascular Patency | 1 | 2015 | 83 | 0.120 |
Why?
| | Endovascular Procedures | 1 | 2017 | 180 | 0.120 |
Why?
| | Serositis | 1 | 2014 | 1 | 0.120 |
Why?
| | Cerebral Hemorrhage | 1 | 2015 | 100 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 165 | 0.110 |
Why?
| | Arkansas | 2 | 2016 | 1974 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2015 | 976 | 0.110 |
Why?
| | Databases, Factual | 4 | 2017 | 676 | 0.100 |
Why?
| | Lithium | 1 | 2013 | 34 | 0.100 |
Why?
| | Calcium | 1 | 2015 | 397 | 0.100 |
Why?
| | Bradycardia | 1 | 2013 | 37 | 0.100 |
Why?
| | Echocardiography, Stress | 1 | 2012 | 9 | 0.100 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2014 | 224 | 0.100 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 386 | 0.100 |
Why?
| | Clostridium septicum | 1 | 2012 | 2 | 0.100 |
Why?
| | Aortitis | 1 | 2012 | 4 | 0.100 |
Why?
| | Dyspnea | 1 | 2012 | 75 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2014 | 276 | 0.100 |
Why?
| | Plaque, Atherosclerotic | 1 | 2012 | 38 | 0.090 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2016 | 263 | 0.090 |
Why?
| | Stroke Volume | 1 | 2012 | 141 | 0.090 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2016 | 286 | 0.090 |
Why?
| | Mice | 1 | 2021 | 5659 | 0.090 |
Why?
| | HIV Infections | 1 | 2015 | 347 | 0.090 |
Why?
| | Clostridium Infections | 1 | 2012 | 55 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2018 | 1030 | 0.090 |
Why?
| | Clinical Competence | 1 | 2014 | 403 | 0.090 |
Why?
| | Logistic Models | 3 | 2017 | 901 | 0.080 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 1601 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 1163 | 0.080 |
Why?
| | Cell Proliferation | 2 | 2023 | 980 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2023 | 1393 | 0.080 |
Why?
| | Child | 1 | 2021 | 6931 | 0.080 |
Why?
| | Animals | 2 | 2021 | 13063 | 0.070 |
Why?
| | Registries | 2 | 2021 | 565 | 0.070 |
Why?
| | Chi-Square Distribution | 2 | 2017 | 275 | 0.070 |
Why?
| | Length of Stay | 2 | 2018 | 631 | 0.060 |
Why?
| | Comorbidity | 2 | 2016 | 621 | 0.060 |
Why?
| | Chromosome Segregation | 1 | 2023 | 12 | 0.050 |
Why?
| | Acyltransferases | 1 | 2023 | 25 | 0.050 |
Why?
| | Sepsis | 2 | 2016 | 225 | 0.050 |
Why?
| | Microtubules | 1 | 2023 | 40 | 0.050 |
Why?
| | Reperfusion Injury | 1 | 2004 | 69 | 0.050 |
Why?
| | Mitosis | 1 | 2023 | 87 | 0.050 |
Why?
| | Androgens | 1 | 2023 | 71 | 0.050 |
Why?
| | Hospitals | 1 | 2022 | 170 | 0.050 |
Why?
| | Parity | 1 | 2020 | 43 | 0.040 |
Why?
| | Aortic Valve | 1 | 2022 | 113 | 0.040 |
Why?
| | Ischemia | 1 | 2021 | 145 | 0.040 |
Why?
| | Sex Factors | 1 | 2022 | 718 | 0.040 |
Why?
| | Materials Testing | 1 | 2019 | 56 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2023 | 831 | 0.040 |
Why?
| | Catheterization | 1 | 2019 | 102 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2004 | 1431 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2020 | 389 | 0.040 |
Why?
| | Cohort Studies | 1 | 2022 | 1451 | 0.040 |
Why?
| | Limb Salvage | 1 | 2017 | 40 | 0.040 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2018 | 107 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2018 | 245 | 0.030 |
Why?
| | Hospital Costs | 1 | 2017 | 71 | 0.030 |
Why?
| | Population Growth | 1 | 2016 | 1 | 0.030 |
Why?
| | Liver Failure | 1 | 2016 | 21 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 573 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 136 | 0.030 |
Why?
| | Counseling | 1 | 2016 | 132 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 223 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 416 | 0.030 |
Why?
| | Self Care | 1 | 2016 | 136 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 906 | 0.030 |
Why?
| | Long-Term Care | 1 | 2015 | 50 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 2016 | 117 | 0.030 |
Why?
| | Risk Assessment | 1 | 2019 | 1268 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 39 | 0.030 |
Why?
| | Arthritis, Psoriatic | 1 | 2014 | 9 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 67 | 0.030 |
Why?
| | New York City | 1 | 2014 | 25 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2016 | 298 | 0.030 |
Why?
| | Internal Medicine | 1 | 2014 | 22 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2014 | 52 | 0.030 |
Why?
| | Pregnancy | 1 | 2020 | 2444 | 0.030 |
Why?
| | Survival Analysis | 1 | 2015 | 658 | 0.030 |
Why?
| | Myocardial Infarction | 1 | 2017 | 402 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 173 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2012 | 268 | 0.020 |
Why?
| | Internship and Residency | 1 | 2014 | 443 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 751 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 3233 | 0.010 |
Why?
| | E-Selectin | 1 | 2004 | 14 | 0.010 |
Why?
| | Papio | 1 | 2004 | 16 | 0.010 |
Why?
| | Blood Gas Analysis | 1 | 2004 | 29 | 0.010 |
Why?
| | Water-Electrolyte Balance | 1 | 2004 | 20 | 0.010 |
Why?
| | Blood Cell Count | 1 | 2004 | 39 | 0.010 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2004 | 44 | 0.010 |
Why?
| | P-Selectin | 1 | 2004 | 31 | 0.010 |
Why?
| | Orbit | 1 | 2004 | 27 | 0.010 |
Why?
| | Neurologic Examination | 1 | 2004 | 75 | 0.010 |
Why?
| | Carotid Arteries | 1 | 2004 | 84 | 0.010 |
Why?
| | Cerebral Arteries | 1 | 2004 | 37 | 0.010 |
Why?
| | Postoperative Care | 1 | 2004 | 103 | 0.010 |
Why?
| | Anesthesia | 1 | 2004 | 73 | 0.010 |
Why?
| | Blood Pressure | 1 | 2004 | 525 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2004 | 460 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2004 | 1546 | 0.010 |
Why?
| | Brain | 1 | 2004 | 1318 | 0.010 |
Why?
|
|
Agarwal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|